BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315
32958 results:

  • 1. Dual‑regulated oncolytic adenovirus carrying
    Zhao T; Ye W; Zhang R; Zhu X; Shi Q; Xu X; Chen W; Xu L; Meng Y
    Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38757346
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.
    Li H; Peng Z; Zhu J; Zhao W; Huang Y; An R; Zheng H; Qu P; Wang L; Zhou Q; Wang D; Lou G; Wang J; Wang K; Kong B; Xie X; Yin R; Low J; Rozita AM; Sen LC; Meng YC; Kiong KS; Liu J; Liang Z; Lv W; Zhu Y; Hu W; Sun W; Su J; Wang Q; Zang R; Ma D; Gao Q
    BMC Med; 2024 May; 22(1):199. PubMed ID: 38755585
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant ovarian cancer: Findings From Cohort A of the OPAL Phase II Trial.
    Liu JF; Gaillard S; Wahner Hendrickson AE; Yeku O; Diver E; Gunderson Jackson C; Arend R; Ratner E; Samnotra V; Gupta D; Chung J; Zhang H; Compton N; Baines A; Bacqué E; Liu X; Felicetti B; Konecny GE
    JCO Precis Oncol; 2024 May; 8():e2300693. PubMed ID: 38754056
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Small Nucleolar RNAs as Diagnostic and Prognostic Biomarkers in cancer: A Systematic Review and Meta-Analysis.
    Gao L; Fan J; He J; Che X; Wang X; Han C
    Technol Cancer Res Treat; 2024; 23():15330338241245939. PubMed ID: 38752263
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CircAGFG1 Promotes ovarian cancer Progression Through the miR-409-3 p/ZEB1 Axis.
    Luo J; Zhong H; Guo M; Xiao P; Cao R; Zhao M; Jing Y
    Technol Cancer Res Treat; 2024; 23():15330338241252423. PubMed ID: 38752261
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of necroptosis-related gene signatures for predicting the prognosis of ovarian cancer.
    Qin Y; Sheng Y; Ren M; Hou Z; Xiao L; Chen R
    Sci Rep; 2024 May; 14(1):11133. PubMed ID: 38750159
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors.
    Chung DC; Ghaedi M; Warner K; Sayad A; Saibil SD; Bernardini MQ; Clarke BA; Shaw PA; Butler MO; Easson A; Morrissy S; Wang BX; Nguyen L; Ohashi PS; Jacquelot N
    Oncoimmunology; 2024; 13(1):2349347. PubMed ID: 38746870
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated β-catenin activation.
    Wang M; Sun Y; Gu R; Tang Y; Han G; Zhao S
    J Ovarian Res; 2024 May; 17(1):101. PubMed ID: 38745186
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Role of Palliative Surgery in the Management of Acute Intestinal Obstruction Secondary to Peritoneal Carcinomatosis.
    Bhat BK; Yadav A; Nundy S
    Chirurgia (Bucur); 2024 Apr; 119(2):218-226. PubMed ID: 38743835
    [No Abstract]    [Full Text] [Related]  

  • 10. [Impact of changes in malignant tumor death spectrum on life expectancy in Tianjin residents from 1999-2019].
    Jiang TT; Wang SY; Yin XL; Xu JH; Wang DZ
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):461-470. PubMed ID: 38742360
    [No Abstract]    [Full Text] [Related]  

  • 11. Blood Lead Level as Marker of Increased Risk of ovarian cancer in BRCA1 Carriers.
    Kiljańczyk A; Matuszczak M; Marciniak W; Derkacz R; Stempa K; Baszuk P; Bryśkiewicz M; Lubiński K; Cybulski C; Dębniak T; Gronwald J; Huzarski T; Lener MR; Jakubowska A; Szwiec M; Stawicka-Niełacna M; Godlewski D; Prusaczyk A; Jasiewicz A; Kluz T; Tomiczek-Szwiec J; Kilar-Kobierzycka E; Siołek M; Wiśniowski R; Posmyk R; Jarkiewicz-Tretyn J; Sun P; Scott RJ; Narod SA; Lubiński J
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732616
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Racial and Ethnic Disparities in the Incidence of Anti-NMDA Receptor Encephalitis.
    Alsalek S; Schwarzmann KB; Budhathoki S; Hernandez-Lopez V; Smith JB; Li BH; Langer-Gould A
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200255. PubMed ID: 38728608
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.
    Zhao J; Wang D; Wang R; He Y; Jia C; Pan L; Ma S; Wu M; Wang W; Cheng X; Yang J; Xiang Y
    J Ovarian Res; 2024 May; 17(1):96. PubMed ID: 38720349
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Risk of Subsequent Primary cancers Among Adult-Onset 5-Year cancer Survivors in South Korea: Retrospective Cohort Study.
    Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
    JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Study of antitumor effects of human placenta hydrolysate on PC-3, OAW-42, BT-474 cell cultures].
    Gromova OA; Filimonova MV; Torshin IY; Frolova DЕ
    Ter Arkh; 2024 Apr; 96(3):266-272. PubMed ID: 38713042
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients.
    Quan C; Chen X; Wen H; Wu X; Li J
    BMC Cancer; 2024 May; 24(1):565. PubMed ID: 38711015
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. piR-1919609 Is an Ideal Potential Target for Reversing Platinum Resistance in ovarian cancer.
    Yan Y; Tian D; Zhao B; Li Z; Huang Z; Li K; Chen X; Zhou L; Feng Y; Yang Z
    Technol Cancer Res Treat; 2024; 23():15330338241249692. PubMed ID: 38706262
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Predictors of Blood Transfusion in Patients Undergoing Cytoreductive Surgeries for ovarian Malignancy.
    Pearce JV; Zhao J; Randall L; Sullivan SA; Miller D; Tossas K
    South Med J; 2024 May; 117(5):266-271. PubMed ID: 38701848
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Persistent organic pollutants dysregulate energy homeostasis in human ovaries in vitro.
    Li T; Björvang RD; Hao J; Di Nisio V; Damdimopoulos A; Lindskog C; Papaikonomou K; Damdimopoulou P
    Environ Int; 2024 May; 187():108710. PubMed ID: 38701644
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The burden of disease due to dietary exposure to acrylamide in Italy: A risk assessment-based approach.
    Mihalache OA; Dall'Asta C
    Food Chem Toxicol; 2024 Jun; 188():114699. PubMed ID: 38697496
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1648.